Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Senators Request Probe Of FDA Conflict of Interest Waivers

This article was originally published in The Pink Sheet Daily

Executive Summary

Increasing concern over FDA advisory committee members’ conflicts of interest prompts Senators Enzi, Kennedy and Durbin to seek assistance from the Government Accountability Office in conducting a review of the policy.

You may also be interested in...

Plan B Language To Be Included In Conference Report On FDA Appropriations

Sen. Murray withdrew four amendments to the Ag Approps bill in exchange for a pledge that language will appear in the report expressing bipartisan concern over the emergency contraceptive’s review process.

Pfizer's Bourla: "I Think We Forgot What It Looks Like To Grow"

The big pharma CEO reflected on his first year of leadership at Pfizer during the Forbes Healthcare Summit and talked about executing on a plan to deliver 6% growth through 2026. 





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts